Ventilation during the treatment of cardiac arrest constitutes a major public health issue, with 50,000 people dying prematurely from cardiac arrest every year, and the survival rate without sequelae at under 5%*. Existing equipment was not tackling the problem adequately, so this partnership allowed Air Liquide Healthcare and Annecy Genevois Hospital Center to develop an effective solution: CPV
* 5% survival rate without sequelae after cardiac arrest. Figure supplied by the French social security system